Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Orgenesis
Sort By
Newest First
Sign in
1 / 1
1 / 1
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
Orgenesis
PR-M11-22-05
Nov 07, 2022
M&A
Catalent Acquires Orgenesis' Cell Therapy Unit
Catalent
PR-M01-20-NI-046
Feb 03, 2020
Collaboration
Secant Group Announces Collaboration between Orgenesis and Atvio Biotech
Secant Group
PR-M08-18-NI-033
Aug 09, 2018
